Musculoskeletal disorders (MSDs) are injuries or pain in the human musculoskeletal system, including the joints, ligaments, muscles, nerves, tendons, and structures that support limbs, neck and back.
Scope of the Report:
MSDs can arise from a sudden exertion (e.g., lifting a heavy object)[2], or they can arise from making the same motions repeatedly repetitive strain, or from repeated exposure to force, vibration, or awkward posture. Injuries and pain in the musculoskeletal system caused by acute traumatic events like a car accident or fall are not considered musculoskeletal disorders. MSDs can affect many different parts of the body including upper and lower back, neck, shoulders and extremities (arms, legs, feet, and hands).[5] Examples of MSDs include carpal tunnel syndrome, epicondylitis, tendinitis, back pain, tension neck syndrome, and hand-arm vibration syndrome.
The global Musculoskeletal Diseases Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Musculoskeletal Diseases Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Musculoskeletal Diseases Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Musculoskeletal Diseases Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
GE
Koninklijke Philips
Siemens
Canon Medical Systems
Hitachi
Shimadzu
Fujifilm
Toshiba
Accuray
MR Solutions
Alltech Medical Systems
Terason Division Teratech
Echo-Son
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)
Ultrasound
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Musculoskeletal Diseases Treatment Market Overview
1.1 Product Overview and Scope of Musculoskeletal Diseases Treatment
1.2 Classification of Musculoskeletal Diseases Treatment by Types
1.2.1 Global Musculoskeletal Diseases Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Musculoskeletal Diseases Treatment Revenue Market Share by Types in 2017
1.2.3 Magnetic Resonance Imaging (MRI)
1.2.4 Computed Tomography (CT)
1.2.5 Ultrasound
1.2.6 Others
1.3 Global Musculoskeletal Diseases Treatment Market by Application
1.3.1 Global Musculoskeletal Diseases Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Musculoskeletal Diseases Treatment Market by Regions
1.4.1 Global Musculoskeletal Diseases Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Musculoskeletal Diseases Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Musculoskeletal Diseases Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Musculoskeletal Diseases Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Musculoskeletal Diseases Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Musculoskeletal Diseases Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Musculoskeletal Diseases Treatment (2013-2023)
2 Manufacturers Profiles
2.1 GE
2.1.1 Business Overview
2.1.2 Musculoskeletal Diseases Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GE Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Koninklijke Philips
2.2.1 Business Overview
2.2.2 Musculoskeletal Diseases Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Koninklijke Philips Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Siemens
2.3.1 Business Overview
2.3.2 Musculoskeletal Diseases Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Siemens Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Canon Medical Systems
2.4.1 Business Overview
2.4.2 Musculoskeletal Diseases Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Canon Medical Systems Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Hitachi
2.5.1 Business Overview
2.5.2 Musculoskeletal Diseases Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hitachi Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Shimadzu
2.6.1 Business Overview
2.6.2 Musculoskeletal Diseases Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Shimadzu Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Fujifilm
2.7.1 Business Overview
2.7.2 Musculoskeletal Diseases Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Fujifilm Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Toshiba
2.8.1 Business Overview
2.8.2 Musculoskeletal Diseases Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Toshiba Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Accuray
2.9.1 Business Overview
2.9.2 Musculoskeletal Diseases Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Accuray Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 MR Solutions
2.10.1 Business Overview
2.10.2 Musculoskeletal Diseases Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 MR Solutions Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 Alltech Medical Systems
2.11.1 Business Overview
2.11.2 Musculoskeletal Diseases Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Alltech Medical Systems Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Terason Division Teratech
2.12.1 Business Overview
2.12.2 Musculoskeletal Diseases Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Terason Division Teratech Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 Echo-Son
2.13.1 Business Overview
2.13.2 Musculoskeletal Diseases Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Echo-Son Musculoskeletal Diseases Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Musculoskeletal Diseases Treatment Market Competition, by Players
3.1 Global Musculoskeletal Diseases Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Musculoskeletal Diseases Treatment Players Market Share
3.2.2 Top 10 Musculoskeletal Diseases Treatment Players Market Share
3.3 Market Competition Trend
4 Global Musculoskeletal Diseases Treatment Market Size by Regions
4.1 Global Musculoskeletal Diseases Treatment Revenue and Market Share by Regions
4.2 North America Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
5 North America Musculoskeletal Diseases Treatment Revenue by Countries
5.1 North America Musculoskeletal Diseases Treatment Revenue by Countries (2013-2018)
5.2 USA Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
6 Europe Musculoskeletal Diseases Treatment Revenue by Countries
6.1 Europe Musculoskeletal Diseases Treatment Revenue by Countries (2013-2018)
6.2 Germany Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
6.4 France Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Musculoskeletal Diseases Treatment Revenue by Countries
7.1 Asia-Pacific Musculoskeletal Diseases Treatment Revenue by Countries (2013-2018)
7.2 China Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
7.5 India Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
8 South America Musculoskeletal Diseases Treatment Revenue by Countries
8.1 South America Musculoskeletal Diseases Treatment Revenue by Countries (2013-2018)
8.2 Brazil Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Musculoskeletal Diseases Treatment by Countries
9.1 Middle East and Africa Musculoskeletal Diseases Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Musculoskeletal Diseases Treatment Revenue and Growth Rate (2013-2018)
10 Global Musculoskeletal Diseases Treatment Market Segment by Type
10.1 Global Musculoskeletal Diseases Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Musculoskeletal Diseases Treatment Market Forecast by Type (2018-2023)
10.3 Magnetic Resonance Imaging (MRI) Revenue Growth Rate (2013-2023)
10.4 Computed Tomography (CT) Revenue Growth Rate (2013-2023)
10.5 Ultrasound Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)
11 Global Musculoskeletal Diseases Treatment Market Segment by Application
11.1 Global Musculoskeletal Diseases Treatment Revenue Market Share by Application (2013-2018)
11.2 Musculoskeletal Diseases Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)
12 Global Musculoskeletal Diseases Treatment Market Size Forecast (2018-2023)
12.1 Global Musculoskeletal Diseases Treatment Market Size Forecast (2018-2023)
12.2 Global Musculoskeletal Diseases Treatment Market Forecast by Regions (2018-2023)
12.3 North America Musculoskeletal Diseases Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Musculoskeletal Diseases Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Musculoskeletal Diseases Treatment Revenue Market Forecast (2018-2023)
12.6 South America Musculoskeletal Diseases Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Musculoskeletal Diseases Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Musculoskeletal Diseases Treatment Picture
Table Product Specifications of Musculoskeletal Diseases Treatment
Table Global Musculoskeletal Diseases Treatment and Rev